These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8216016

  • 1. Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Kuppermann BD, Flores-Aguilar M, Quiceno JI, Rickman LS, Freeman WR.
    Arch Ophthalmol; 1993 Oct; 111(10):1359-66. PubMed ID: 8216016
    [Abstract] [Full Text] [Related]

  • 2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
    Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Jacobson MA, Wulfsohn M, Feinberg JE, Davis R, Power M, Owens S, Causey D, Heath-Chiozzi ME, Murphy RL, Cheung TW.
    AIDS; 1994 Apr; 8(4):451-9. PubMed ID: 8011248
    [Abstract] [Full Text] [Related]

  • 5. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
    Desatnik HR, Foster RE, Lowder CY.
    Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
    [Abstract] [Full Text] [Related]

  • 6. Morbidity and toxic effects associated with ganciclovir or foscarnet therapy in a randomized cytomegalovirus retinitis trial. Studies of ocular complications of AIDS Research Group, in collaboration with the AIDS Clinical Trials Group.
    Arch Intern Med; 1995 Jan 09; 155(1):65-74. PubMed ID: 7802522
    [Abstract] [Full Text] [Related]

  • 7. [Foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome].
    Nagata Y, Fujino Y, Ono A, Mochizuki M, Mouri H, Oka S, Kimura S, Shimada K.
    Nippon Ganka Gakkai Zasshi; 1994 Jul 09; 98(7):710-5. PubMed ID: 8067306
    [Abstract] [Full Text] [Related]

  • 8. Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome.
    Guembel HO, Hofmann F, van Even G, Cinatl J, Makabe R.
    Ger J Ophthalmol; 1996 Nov 09; 5(6):490-1. PubMed ID: 9479542
    [No Abstract] [Full Text] [Related]

  • 9. Viral sensitivity testing in patients with cytomegalovirus retinitis clinically resistant to foscarnet or ganciclovir.
    Dunn JP, MacCumber MW, Forman MS, Charache P, Apuzzo L, Jabs DA.
    Am J Ophthalmol; 1995 May 09; 119(5):587-96. PubMed ID: 7733184
    [Abstract] [Full Text] [Related]

  • 10. Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis.
    Weinberg DV, Murphy R, Naughton K.
    Am J Ophthalmol; 1994 Jun 15; 117(6):776-82. PubMed ID: 8198162
    [Abstract] [Full Text] [Related]

  • 11. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis.
    Flores-Aguilar M, Kuppermann BD, Quiceno JI, Dankner WM, Wolf DG, Capparelli EV, Connor JD, Sherwood CH, Fullerton S, Gambertoglio JG.
    Ophthalmology; 1993 Jul 15; 100(7):1022-31. PubMed ID: 8391674
    [Abstract] [Full Text] [Related]

  • 12. Foscarnet and ganciclovir pharmacokinetics during concomitant or alternating maintenance therapy for AIDS-related cytomegalovirus retinitis.
    Aweeka FT, Gambertoglio JG, Kramer F, van der Horst C, Polsky B, Jayewardene A, Lizak P, Emrick L, Tong W, Jacobson MA.
    Clin Pharmacol Ther; 1995 Apr 15; 57(4):403-12. PubMed ID: 7712668
    [Abstract] [Full Text] [Related]

  • 13. Current management of cytomegalovirus disease in patients with AIDS.
    Jacobson MA.
    AIDS Res Hum Retroviruses; 1994 Aug 15; 10(8):917-23. PubMed ID: 7811543
    [Abstract] [Full Text] [Related]

  • 14. Controversies in the treatment of cytomegalovirus retinitis: foscarnet versus ganciclovir.
    Jabs DA.
    Infect Agents Dis; 1995 Sep 15; 4(3):131-42. PubMed ID: 8548191
    [Abstract] [Full Text] [Related]

  • 15. Design of clinical trials for drug combinations: cytomegalovirus retinitis--foscarnet and ganciclovir. The CMV retinitis retreatment trial.
    Jabs DA.
    Antiviral Res; 1996 Jan 15; 29(1):69-71. PubMed ID: 8721550
    [Abstract] [Full Text] [Related]

  • 16. Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
    Dodds EM, Lowder CY, Foster RE, Avery RK, Prayson RA.
    Arch Ophthalmol; 1996 Jul 15; 114(7):896-7. PubMed ID: 8660181
    [No Abstract] [Full Text] [Related]

  • 17. Advances in treatment for cytomegalovirus retinitis.
    Bowers M.
    BETA; 1995 Sep 15; ():13-5. PubMed ID: 11362885
    [Abstract] [Full Text] [Related]

  • 18. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
    Am J Ophthalmol; 1997 Jul 15; 124(1):61-70. PubMed ID: 9222234
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy.
    Ries E, Mühlbauer B, Ruhswurm I, Krepler K, Derbolav A, Svolba G, Rieger A, Wedrich A.
    Ophthalmologica; 1998 Jul 15; 212(4):239-43. PubMed ID: 9672212
    [Abstract] [Full Text] [Related]

  • 20. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
    Ophthalmology; 1994 Jul 15; 101(7):1250-61. PubMed ID: 8035989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.